Lv41
524 积分 2024-10-29 加入
4-Arylindolines Bearing a Pyrido[3,2-d]pyrimidine Scaffold as Dual Inhibitors of the PD-1/PD-L1 Interaction and NAMPT for Targeting Tumor Immunoevasion and Metabolism
11小时前
已完结
DCPDC-Mediated Facile Amide-Bond Formation of Non-Nucleophilic and Hindered Amines
20天前
已完结
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
3个月前
已完结
The expanding repertoire of covalent warheads for drug discovery
3个月前
已完结
Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer
3个月前
已完结
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial
5个月前
已完结
Recent Study of Dual HDAC/PARP Inhibitor for the Treatment of Tumor
5个月前
已完结
Tumour hypoxia in driving genomic instability and tumour evolution
6个月前
已完结
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
6个月前
已完结
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
6个月前
已完结
皖公网安备34019202002308
